Most jurisdictions do not consider obesity to be a disability under the Americans with Disabilities Act (ADA), except for Louisiana and Mississippi, [4] unless obesity is caused by an underlying health condition
Both oral and injectable semaglutide carry similar risks, including: Acute pancreatitis Diabetic retinopathy complications (diabetes-related vision changes) Hypoglycemia (low blood sugar), especially when used with insulin Kidney or gallbladder issues Severe gastrointestinal reactions Allergic reactions Pulmonary aspiration during general anesthesia or deep sedation Additionally, Wegovy carries warnings for increased heart rate and suicidal behavior or ideation
Matsumoto, K
Keeping an eye on health markers like blood pressure, cholesterol levels, and blood sugar can help evaluate the success of semaglutide treatment over time
Verify that any compounding pharmacy is properly licensed, uses third-party testing, and follows current good manufacturing practices
This is a huge plus for anyone who experiences intense cravings and has a problem with overeating